VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PAVMPAVmed Inc.
$4.98$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPAVMQuarterly Financials

PAVmed Inc. (PAVM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

PAVmed Inc. (PAVM) quarterly income statement — complete revenue, gross profit & net income history

PAVM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue22M52K5K6K8K10K996K979K1.01M1.05M791K166K
Revenue Growth %274900%420%-99.5%-99.39%-99.21%-99.05%25.92%489.76%126.46%836.61%940.79%-
Cost of Goods Sold97M103K55K41K79K48K1.38M1.97M1.74M1.61M1.78M1.69M
COGS % of Revenue440.91%198.08%1100%683.33%987.5%480%138.65%201.33%172.67%153.57%224.91%1015.06%
Gross Profit-75M-51K-50K-35K-71K-38K-385K-992K-734K-562K-988K-1.52M
Gross Margin %-340.91%-98.08%-1000%-583.33%-887.5%-380%-38.65%-101.33%-72.67%-53.57%-124.91%-915.06%
Gross Profit Growth %-105533.8%-34.21%87.01%96.47%90.33%93.24%61.03%34.69%18.44%62.68%36.26%-
Operating Expenses7.96B6.75M4.79M4.68M5.38M5.15M11.19M12.69M13.3M15.82M14.54M14.96M
OpEx % of Revenue36181.82%12984.62%95880%78000%67187.5%51490%1123.8%1296.42%1317.03%1508.2%1838.18%9015.06%
Selling, General & Admin6.57B17.15B3.71M3.89M4.63M4.34M9.57M11.25M10.99M11.72M10.87M10.99M
SG&A % of Revenue29872.73%32989948.08%74120%64833.33%57887.5%43420%960.74%1149.23%1088.02%1117.35%1374.72%6621.08%
Research & Development1.39B1.83M1.09M790K787K807K1.54M1.64M1.94M3.6M3.16M3.47M
R&D % of Revenue6309.09%3515.38%21760%13166.67%9837.5%8070%154.82%167.62%192.18%342.71%399.62%2089.76%
Other Operating Expenses0-1000K00-43K082K-200K372K505K505K505K
Operating Income-8.04B-6.8M-4.84M-4.71M-5.45M-5.19M-11.58M-13.68M-14.04M-16.38M-15.53M-16.48M
Operating Margin %-36522.73%-13082.69%-96880%-78583.33%-68075%-51870%-1162.45%-1397.75%-1389.7%-1561.77%-1963.08%-9930.12%
Operating Income Growth %-147439.48%-31.15%58.16%65.54%61.2%68.34%25.44%16.99%31.2%33.41%33.55%29.81%
EBITDA-8.03B-6.79M-4.82M-4.69M-5.4M-5.12M-11.34M-13.38M-13.45M-15.66M-14.79M-15.74M
EBITDA Margin %-36522.64%-13048.08%-96440%-78216.67%-67537.5%-51180%-1138.55%-1366.6%-1331.68%-1492.66%-1870.42%-9480.12%
EBITDA Growth %-148613.31%-32.57%57.48%64.92%59.83%67.31%23.35%14.98%31.64%34.42%34.73%30.58%
D&A (Non-Cash Add-back)20K18K22K22K43K69K238K305K586K725K733K747K
EBIT-8.04B-6.8M-6M-12.32M18.63M1.15M60.72M-14.9M-18.5M-17.39M-21.59M-17.66M
Net Interest Income16K02K4K4K-5K58K99K56K78K-35K-65K
Interest Income19K5K10K8K8K2K70K110K72K97K124K163K
Interest Expense3K5K8K4K4K7K12K11K16K19K159K228K
Other Income/Expense6.97B4.04M-1.17M-7.61M24.07M6.33M72.29M-1.23M-4.48M-1.02M-6.22M-1.41M
Pretax Income-1.06B-2.76M-6.01M-12.32M18.62M1.14M60.71M-14.91M-18.51M-17.41M-21.75M-17.89M
Pretax Margin %-4836.36%-5301.92%-120220%-205400%232787.5%11420%6095.48%-1523.39%-1832.87%-1659.49%-2749.68%-10778.31%
Income Tax5.92B00000000000
Effective Tax Rate %-556.77%0%0%0%0%0%0%0%0%0%0%0%
Net Income-6.99B-1.26M-5.38M-11.92M18.97M1.43M64.4M-10.83M-15.21M-14.04M-17.67M-14.54M
Net Margin %-31763.64%-2428.85%-107660%-198683.33%237100%14310%6465.76%-1105.92%-1506.14%-1338.04%-2234.01%-8757.23%
Net Income Growth %-36941%-188.26%-108.36%-10.1%224.69%110.2%464.43%25.52%15.16%31.4%32.36%43.05%
Net Income (Continuing)-6.99B-2.76M-6.01M-12.32M18.62M1.14M60.71M-14.91M-18.51M-17.41M-21.75M-17.89M
Discontinued Operations000000000000
Minority Interest-14.54M-11.67M-9.99M-9.37M-6.06M-4.54M-4.52M55.3M48.2M29.81M27.43M30.68M
EPS (Diluted)-442058.01-2.37-8.70-22.2010.113.6143.22-35.75-78.62-58.07-71.35-63.01
EPS Growth %-4371285.7%-165.72%-120.13%37.91%112.86%106.21%160.58%43.26%5.78%40.6%45.67%52.43%
EPS (Basic)-442058.01-2.37-8.70-22.2038.263.61192.84-35.75-78.62-58.07-71.35-63.01
Diluted Shares Outstanding15.81K773.64K718.49K602.82K1.75M373.3K1.48M305.09K289.83K267.43K248.76K231.89K
Basic Shares Outstanding15.81K773.64K718.49K602.82K462.54K373.3K333.51K305.09K289.83K236K248.76K231.89K
Dividend Payout Ratio------------